touchPODCAST

The use of biologics in children with severe type 2 asthma

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

The use of biologics in children with severe type 2 asthma

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

Accurately diagnosing severe type 2 asthma in children

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and  Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

Accurately diagnosing severe type 2 asthma in children

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.

The multidisciplinary team:

• Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
• Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
• Patient advocate: Ms Monique Cooper, Miami, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

MDT perspectives on the current and emerging second-line treatment options for SCLC

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting.

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on managing side effects associated with second-line treatment for SCLC

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/ 

MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC

Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options

 The multidisciplinary team

• Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
• Pulmonologist: Dr Christine Argento, Maryland, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on managing side effects associated with second-line treatment for SCLC

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options

 The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Pulmonologist: Dr Christine Argento, Johns Hopkins University, Baltimore, MD

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/

 

MDT perspectives on the current and emerging second-line treatment options for SCLC

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting

The multidisciplinary team:

• Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
• Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/